Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.

Khan K, Xu S, Nihtyanova S, Derrett-Smith E, Abraham D, Denton CP, Ong VH.

Ann Rheum Dis. 2012 Jul;71(7):1235-42. doi: 10.1136/annrheumdis-2011-200955. Epub 2012 May 14.

PMID:
22586157
2.

The significance of interleukin-6 and C-reactive protein in systemic sclerosis: a systematic literature review.

Muangchant C, Pope JE.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):122-34. Epub 2013 Jul 23. Review.

PMID:
23910616
3.

Mortality in systemic sclerosis.

Karassa FB, Ioannidis JP.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S85-93. Review.

PMID:
19026149
4.

Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature.

Frech TM, Hudson M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S179-81. Epub 2015 Sep 1. Review.

PMID:
26339896
5.

Treatment of early diffuse systemic sclerosis skin disease.

Frech TM, Shanmugam VK, Shah AA, Assassi S, Gordon JK, Hant FN, Hinchcliff ME, Steen V, Khanna D, Kayser C, Domsic RT.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):166-71. Epub 2013 Jul 23. Review.

6.

Interleukin-6: a new therapeutic target in systemic sclerosis?

O'Reilly S, Cant R, Ciechomska M, van Laar JM.

Clin Transl Immunology. 2013 Apr 12;2(4):e4. doi: 10.1038/cti.2013.2. eCollection 2013 Apr. Review.

Supplemental Content

Support Center